Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.

Literature DB >> 6772095

Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.

Abstract

Vancomycin determinations were performed in the presence of an aminoglycoside or rifampin. A previously reported bioassay method was modified by using a rifampin-resistant strain and increasing the NaCl concentration in the minimal salts-glucose assay agar from 0.2 to 6.0%.

Entities: Chemical

Mesh：

Substances：

Year: 1980 PMID： 6772095 PMCID： PMC283860 DOI： 10.1128/AAC.17.4.730

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.

Authors: R J Faville; D E Zaske; E L Kaplan; K Crossley; L D Sabath; P G Quie
Journal: JAMA Date: 1978-10-27 Impact factor: 56.272

2. Vancomycin.

Authors: J E Geraci
Journal: Mayo Clin Proc Date: 1977-10 Impact factor: 7.616

3. Sensitive bioassay for vancomycin.

Authors: C A Walker; B Kopp
Journal: Antimicrob Agents Chemother Date: 1978-01 Impact factor: 5.191

4. Vancomycin-streptomycin synergism in enterococcal endocarditis.

Authors: G O Westenfelder; P Y Paterson; B E Reisberg; G M Carlson
Journal: JAMA Date: 1973-01-01 Impact factor: 56.272

5. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.

Authors: C Watanakunakorn; C Glotzbecker
Journal: J Med Microbiol Date: 1977-02 Impact factor: 2.472

6. Antimicrobial therapy of experimental enterococcal endocarditis.

Authors: E W Hook; R B Roberts; M A Sande
Journal: Antimicrob Agents Chemother Date: 1975-11 Impact factor: 5.191

7. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

Authors: C Watanakunakorm; C Glotzbecker
Journal: Antimicrob Agents Chemother Date: 1974-12 Impact factor: 5.191

Review 8. Vancomycin revisited.

Authors: F V Cook; W E Farrar
Journal: Ann Intern Med Date: 1978-06 Impact factor: 25.391

9. In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors: C U Tuazon; M Y Lin; J N Sheagren
Journal: Antimicrob Agents Chemother Date: 1978-05 Impact factor: 5.191

10. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

Authors: H J Harwick; G M Kalmanson; L B Guze
Journal: Antimicrob Agents Chemother Date: 1973-10 Impact factor: 5.191

5 in total

1. Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.

Authors: B H Ackerman; H G Berg; R G Strate; J C Rotschafer
Journal: J Clin Microbiol Date: 1983-10 Impact factor: 5.948

2. Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.

Authors: S B Calderwood; C C Tung; E Jackson
Journal: J Clin Microbiol Date: 1984-05 Impact factor: 5.948

3. Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay.

Authors: M A Pfaller; D J Krogstad; G G Granich; P R Murray
Journal: J Clin Microbiol Date: 1984-09 Impact factor: 5.948

4. Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.

Authors: D J Pohlod; L D Saravolatz; M M Somerville
Journal: J Clin Microbiol Date: 1984-08 Impact factor: 5.948

Review 5. Clinical pharmacokinetics of vancomycin.

Authors: G R Matzke; G G Zhanel; D R Guay
Journal: Clin Pharmacokinet Date: 1986 Jul-Aug Impact factor: 6.447

5 in total